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Abstract 
Objective: To determine the frequency of COVID-19 and characteristics of patients presenting to the COVID-19 
clinic at Qazi Hussain Ahmed Medical Complex (QHAMC) Nowshera. 
Methodology: This cross-sectional study was conducted from 21st Feb 2019 to April 8, 2020, in QHAMC 
Nowshera. Relevant information was collected on a pre-designed Performa prepared following the objectives of 
the study. 
Results: Out of 220 patients, 165(75%) were males, and 55(25%) females. 96(43.6%) of the patients were in the age 
range 18-30 years followed by 52(23.6%) in age range 31-45years and 17(7.7%) with age>60 years etc. Out of total 
the nasopharyngeal swabs of 26(11.6%) strong suspects were sent for PCR testing. 208(94.5%) were sent home 
while 12(5.5%) were advised quarantine. Forty-seven (21.4%) had a travel history to an epidemic area in the last 
14 days. 51(23.2%) had a positive history of contact. Eighty-five (38.6%) had a fever and sore throat followed by 
27(12.3%) with (fever & cough), 24(10.9%) with (cough and shortness of breath/dyspnea) and 14(6.4%) with a 
simple flue, etc. Out of 26 cases, 6(2.7%) were COVID-19 Positive, 12(5.5%) were negative and results of 8(3.6%) 
were still awaited. The PCR repeated the test for confirmed cases showed;  4(1.8%) negative, one died and one 
was refractory positive.  A positive correlation (p=0.03, r=0.4) of an increase in age with the severity of the 
disease/outcome was recorded.  
Conclusion: The frequency of infectivity with COVID-19 was 2.6%. A higher number of patients with mild 
symptoms attend the COVID clinic. The rate of infection and mortality was higher in age> 60 years. 
Keywords: COVID-19, rate of infection, mortality, quarantine, provoking factors.  
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Introduction 
 
Corona Virus disease termed as COVID-19 is an 
emerging highly contagious respiratory disease that is 
caused by the novel coronavirus. It was first reported 
from Wuhan, a metropolitan city in the province of 
Hubei China, in December 2019. Its main clinical 
symptoms are fever, dry cough, fatigue, myalgia, and 
dyspnea. World Health Organization (WHO) declared 
it as pandemic on March 11, 2020.1   
Scientists with their previous experience of viral 
epidemics in the form of SARS IN 2002 and Middle 
East Respiratory Syndrome MERS in 2012, helped 
them understand the epidemiology, pathogenesis, and 
treatment of COVID-19. 
Until now what we know about the COVID-19, is that 
it is a respiratory infection of unknown etiology and 
has quickly spread globally.2 The case fatality rate of 
2.3% has been reported from China that is lower than 
SARS (9.5%), MERS (34.4%), and H7N9 (39%).3  
In Pakistan the literature so for covering the 
prevalence and incidence is deficient and we found no 
published data, however, the so for reported data from 
government sources declares 4000 confirmed cases 
with 54 deaths. Punjab is the province with the highest 
number of corona cases reaching 2000.4 
In Pakistan, the virus entered on 26th February 2020, 
when the Government of Pakistan officially declared a 
student of the University of Karachi diagnosed as 
COVID-19 positive, with a travel history of Iran.5 
According to the federal government reports the cases 
can reach as up to 50000 by 25th April 2020 which is 
quite alarming.6 Its main clinical symptoms are fever, 
dry cough, fatigue, myalgia and dyspnea.7 
Little is known about the management plan for this 
deadly disease. In China, the majority of the patients 
(90%) presented with fever, cough (76%), and fatigue 
(32%). Chest X-ray and Computed Tomography (CT) 
showed bilateral patchy shadows in these patients. 
They were treated with antiviral and on the same 
pattern along with traditional treatment for this viral 
pneumonia.8 
Gender and age matters when there is talk about the 
prognosis and outcome of COVID-19. The New York 
Times has reported that coronavirus is striking and 
felling more Italian males as compared to females in 
extreme of age because of their weak immune status. 
Furthermore, the Italian model of mortality is a trend 
mirror of what observed in China with a higher death 
rate in the male gender and older age9. Studies from 
China have reported that individuals with an extreme 
of age and those with immune-compromised status 
like diabetes etc are at more at risk of 2019-nCoV 
infection10.  
Therefore the present study was designed to 
determine the frequency of COVID-19 and 
characteristics of patients presenting to the COVID-19 
clinic of Qazi Hussain Ahmed Medical Complex 
(QHAMC) Nowshera. 
 
Material & Methods 
 
This cross-sectional study was conducted from 21st Feb 
2019 to April 8, 2020, in the COVID-19 clinic of 
QHAMC Nowshera. A total of 220 suspected were 
included in the study. All the suspects attended the 
COVID-19 clinic irrespective of age and gender were 
randomly included. The sampling technique was 
based on convenient probability sampling. All patients 
irrespective of the type of symptoms attending 
emergency or outdoor patients departments were 
excluded. However, if any suspect was referred by the 
consultant for opinion/nasopharyngeal sample 
collection for PCR, he/she was entertained in the 
COVID-19 clinic and he/she became a part of our 
sampling. 
The ethical endorsement was obtained from the 
institutional ethical review board of the Nowshera 
Medical College hospital administration before the 
execution of the survey. Prior informed consent was 
obtained from all suspects and they were assured of 
confidentiality. 
All those suspects with a score of more than 5 on the 
scale approved by the competent authority, were 
enrolled for the collection of nasopharyngeal swabs for 
detection of  COVID-19. All the samples were sent 
under strict observance of protocols to the public 
health research laboratory of Khyber Medical 
University Peshawar (a designated Lab for PCR of 
2019nCoV by the Government of Khyber 
Pukhtunkhwa). 
Till the availability of the report, the strong suspects 
were isolated in hospitals or quarantines of the 
Government of KP.  Some of the cases were isolated at 
home under strict observance of the health/district 
administration to ensure to contain viruses. 
Results were received in 2- 3 days. All positive cases 
were isolated and treatment started, and their sample 
was repeated after 7 days of isolation/treatment. 
Those who were negative in repeated sample 
reporting were shifted to quarantine and one 
refractory positive was kept under strict isolation. 
Data was entered in SPSS 25th version and descriptive 
and correlation statistics were applied. The frequency 
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and proportion of numerical and categorical variables 
were presented in percentages. Pearson correlation test 
was used to show the correlation of age and gender 
with the rate of infectivity and outcome of the disease. 
The criteria and scoring for patient selection for PCR 
testing are mentioned in Table 1. 
Table 1: Criteria for COVID-19 scoring system 
Criteria for COVID-19 scoring system 
Fever  or flu (1) 
Cough (1) 
Sore throat (1)  
Myalgia, body aches (2) 
Shortness of breath (2) 
Travel history to an epidemic area (2) 
Contact history with a traveler of the epidemic area, 
patient with chest pain, mass gathering, patients 
with leucopenia or  lymphopenia (1) 
Contact history with confirm case (6) 
Total (16) 
Strategy to  act: 
Score <5 :  Quarantine  
Score: 6-8  Do Labs & Inform Focal Person 
Score: 8-10 Labs: Needs Isolation/admission 
inform Focal Person 
 
Results 
  
We received 220 patients in COVID-19 clinic, 165(75%) 
were males and 55(25%) females. The majority of the 
patients were in the age range 18-30 years 96(43.6%), 
followed by 52(23.6%) in age range 31-45years and 
17(7.7%) with age>60 years, etc (Table 2).  
Out of the total suspects attending the COVID Clinic, 
47(21.4%) had a travel history to an epidemic area and 
51(23.2%) had a positive history of contact. 16(7.3%) 
had a contact history of 48 hours, flowed by more than 
5 days in 11(5%). The majority of the patients 
85(38.6%) had a fever and sore throat, followed by 
24(10.9%) with cough and shortness of breath, etc. To 
reduce the cost and to discourage the overflow of a 
patient for PCR test due to limited resources and a 
limited number of universal/Viral transport media 
(UTM/VTM),  a scoring system was approved by the 
clinicians and endorsed by the administration that 
contained values for different variables. Hence 
patients score less than 5 were not advised PCR. Only 
26 (11.8%) with a score of more than 5 were advised 
swabs collection for viral detection of COVID-19. 
(Table 3) 
Out of 26 cases, 6(2.7%) were COVID-19 Positive and 
12(5.5%) were negative. Out of the total, 17(7.7%) 
strong suspects have advised isolation in Qazi Hussain 
Ahmed Medical Complex, followed by 15(6.8%) were 
sent home with an intimation of district health 
administration. 
The test was repeated after one week, 4(1.8%) were 
negative, one died and 1(0.5%) was still positive. Out 
of those 26, 25(11.4%) were clinically stable, and one 
female lady aged 85 years died in hospital, who had 
other co-morbidities as well as pneumonia and 
cardiac. (Table 4) 
We observed a moderate uphill positive correlation 
(p=0.03, r=0.4) of an increase in age with the severity of 
the disease/outcome. And that was the reason 
probably of the first corona death observed in our 
hospital (age 85 years). (Table 5) 
Table 2: Demographic characteristics of patients (n=220) 
Categories Frequency (Percentage) 
 Gender 
Male 165(75%) 
Female 55(25%) 
Age 
<18 years 30(13.6%) 
 (18-30 years) 96(43.6%) 
(31-45 years) 52(23.6%) 
(46-60 years) 25(11.4%) 
(>60 years) 17(7.7%) 
 
Table 3: History of Chief complaints, Travel, and Contact 
with strong suspects/Confirmed cases(n=220) 
Categories Frequency (Percentage) 
Travel history to an epidemic area 
Yes 47(21.4%) 
No 173(78.6%) 
Duration of contact 
2-5 hours 10(4.5%) 
48 hours 16(7.3%) 
Up to five days 2(0.9%) 
>5 days 11(5%) 
Not remembered 12(5.5%) 
No Contact 169(76.8%) 
Symptoms/Clinical Features 
152                                                                             Journal of Rawalpindi Medical College (JRMC); 2020; 24(2): 149-155 
Flu 14(6.4%) 
Fever  + cough 1(0.5%) 
Fever  and  sore throat 85(38.6%) 
Fever, cough,  and flu 27(12.3%) 
Cough with blood-tinged 
sputum 
1(0.5%) 
Cough with Shortness of 
Breath/Dyspnea  
24(10.9%) 
Self Isolation 8(3.6%) 
No Symptoms 60(27.3%) 
Scoring of a patient on laid down criteria 
2.00 8(3.6%) 
3.00 120(54.5%) 
4.00 66(30%) 
6.00 5(2.3%) 
7.00 13(5.9%) 
8.00 8(3.6%) 
Total 220(100%) 
 
Table 4:  Description of infectivity, isolation, refractory 
Covid-19, and outcome of the disease 
 Categories Frequency (Percentage) 
PCR Result 
Negative 12(5.5%) 
Positive 6(2.7%) 
Awaited 8(3.6%) 
Not done 194(88.2%) 
Quarantined/Isolation 
Home 15(6.8%) 
Quarantine 2(0.9%) 
Qazi Hussain Ahmed Medical 
Complex 
17(7.7%) 
No Isolation 186(84.5%) 
 Repeated Sample result 
Negative 4(1.8%) 
Positive 1(0.5%) 
Not applicable 21(9.5%) 
Total 26(11.8%) 
System could not catch 194(88.2%) 
Outcome of the disease 
  
Stable 25(11.4%) 
Died 1(0.5%) 
Total 26(11.8%) 
 
Table 5: Correlation of infectivity (PCR-Positivity for 2019-
nCoV) with the outcome of the disease and  age 
Correlations Age 
Categ
ories 
PCR 
Result 
Patient 
condition/
outcome 
Age 
categories 
Pearson 
Correlation 
1 0.020 0.424* 
Sig. (2-tailed) ----- 0.766 0.031 
N 220 220 26 
PCR 
Result 
Pearson 
Correlation 
0.020 1 .036 
Sig. (2-tailed) 0.766 ----- 0.863 
N 220 220 26 
Patient 
condition 
Pearson 
Correlation 
.424* .036 1 
Sig. (2-tailed) 0.031 0.863 ----- 
N 26 26 26 
* Correlation is significant at the 0.05 level (2-tailed). 
 
Discussion 
 
 To the best of our knowledge, this is the first study to 
give information on symptoms, clinical features, 
frequency, and outcome of the COVID-19. The disease 
outbreak in 2019 was different from the presentation 
of pneumonia of unknown cause, later on, the Chinese 
Centre for Disease Control and Prevention and local 
CDC attributed it to a novel virus belonging to the 
corona family and was termed as 2019-nCoV.11 In 
China, unprecedented measures were taken well in 
time to control the rapid spread of COVID-19 
epidemics in china. They succeeded to adhere people 
to homes that were properly achieved by their 
improved Knowledge, attitude, and practices towards 
COVID-19.12 
In the present study, out of 220, 26(11.6%) cases were 
selected for nasopharyngeal swabs for PCR. Living in 
a developing country there are so many constraints 
and hindrances in achieving success to fight against 
communicable diseases like COVID-19. The virus 
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transmission media (VTM) provided by the 
government was limited like in quantity of 20 to thirty, 
so it was decided by the administration with the 
consultation of clinician and microbiologist to make 
use of these VTM under observance of strict criteria. 
Secondly, there is a stigma associated with COVID-19, 
people have got a stat of anxiety and depression, and 
they rush for tests to reduce the level of anxiety. The 
best test is PCR detection f 2019-nCoV as declared by 
the government that is costly and not affordable to all 
sectors as well as drains government resources. 
Scoring in such a situation is the need for time to avoid 
wastage of resources. In many countries, they keep in 
mind the risk factors in the form of age, gender, travel 
history, higher markers level like d-dimers>1ug/ml, 
etc are the clues that help clinicians to identify patients 
for further trial/testing to avoid wastage of 
resources.13 
In the present study out of the total suspects that 
attended the COVID Clinic, 47(21.4%) had a travel 
history to an epidemic area in the last 14 days. Travel 
history has its importance in the transmission of 
COVID-19. Countries have imposed strict restrictions 
on travel including the borders restrictions especially 
for the people of China, or those who travelled China 
in the last 14 days, to contain the virus.14 
We observed 27(12.3%) suspects attending the COVID 
clinic had a contact history of more than 48 hours of 
being a healthcare worker in a hospital with isolation 
units for COVID-19 patients. It is pertinent to mention 
that in the present study, two positive cases among the 
six are brother. One case that is repeatedly positive 
after 7 days, relates the types of contact to a religious 
mass gathering for more than five days in Karachi. As 
for corona infection, person to person transmission is 
well learned from the data of China and Italy. 
Epidemiological investigations were carried out 
among the close relatives of the COVID patients, and 
they observed mild to severe types of clinical 
features/manifestations in these contacts. However, 
the communicable period can last for up to three 
weeks to develop symptoms.11,15 
Regarding the clinical features of the disease, 
85(38.6%) of the suspects presented with fever and 
sore throat to COVID clinic, followed by 27(12.3%) 
with fever & cough and 24(10.9%) with cough with 
shortness of breath. Studies from the epidemic areas 
have reported different presentations of COVID 
suspects/patients.  A study from China reported fever 
(23, 82.1%), dry cough (22, 81%) and dyspnoea (14, 
50.0%) and lymphopenia (23, 82.1%) in their study 
patients.16 Similarly, Zhao D et al17 also reported The 
most common symptoms were fever and cough (78%) 
cases, which coincides with our findings.  
Out of 26 cases where PCR was done, 6(2.7%) were 
COVID-19 Positive, 12(5.5%) were negative and results 
of 8(3.6%) were still awaited. The positivity rate of 
COVID-19 in our suspects was 2.7%. A study from 
Japan reported a higher proportion of asymptomatic of 
17.9% (95% confidence interval (CI: 15.5–20.2%). They 
further stated that infection in the majority of the 
patient has occurred before they join quarantine.18 
Other studies with different proportions of COVID 
positive cases in suspected/asymptomatic patient’s 
findings are shown in Table 6. 
 
Table 6: Comparison of proportion of positivity of 
COVID-19 among the suspected/asymptomatic 
population 
Present 
study 
Khan 
H et al 
Mizumoto 
K et al 18 
Zhou X 
et al 19 
Quilty 
BJ et 
al20 
Tian 
S et 
al,21 
2.7% 17% 4% 17% 5% 
 
We repeated the sampling for virus detection after 7 
days as per government guidelines we observed that  
4(1.8%) cases were negative, one died and 1(0.5%) was 
still positive. Data of the Chinese centre for disease 
control and prevention reported that in 72000 COVID-
19 patients the fatality rate was 2.7%.22 The WHO-
China joint mission on coronavirus disease published 
on 28th Feb 2020, showed a mortality of COVID-19 as 
7.6% in cases with co-morbidities. Otherwise the 
overall mortality due to corona infection in 3.8%, and 
it is further 1.4% when there is no associated co-
morbidity.23 
There was a moderate uphill positive correlation 
(p=0.03, r=0.4) of an increase in age with the severity of 
the disease/outcome. And that was the reason 
probably of the first corona death observed in our 
hospital (age 80 Years). Italy is the second most 
affected country, with more thah40000 cases of SARS-
CoV infection. They attributed these infections with 
poor compliance of the people towards precautionary 
measures during the early stages of the current 
epidemic in the country, and the mortality is higher in 
age people as compared to the younger population, 
which identifies an immunity gap.24 Another study 
from China reported 80% of the causalities (deaths) 
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due to COVID-19 were in the adults aged>60 years as 
compared to 0.1% in a person aged <19 years.25 
Similarly, a positive correlation (p=0.01, r=0.5) of 
female gender with the severity of the 
disease/outcome was noted. In one male patient, the 
second result after 7 days was still positive, but he was 
clinically stable with no deterioration in health status. 
And one case of death noted in females with age >60. 
However, the literature is still in search of gender 
conflict in acquiring the disease.  A study reported that 
SARS-CoV-2 has infected more men than women 
(0.31/100,000 versus 0.27/100,000).26 
 
Conclusion 
 
A higher number of patients with low scores attended 
the COVID-19 clinic that shows the stigma of the 
disease. Due to limited resources, the criteria were 
strict for the selection of suspects for PCR testing.  The 
male gender infectivity rate is higher. Age more than 
60 years has a poor prognosis in COVID-19 infection. 
There is a strong correlation between COVID 
infectivity and mortality with an increase in age.  
Therefore it is suggested that special care should be 
given to suspects with higher risks like in age<5years 
& age >60 years, and patients with immunity gaps. 
There were some unavoidable limitations in the study 
like limited resources, limited VTM/UTM, short 
duration of the study, and a low number of positive 
cases, though we had an acceptable population of 
suspects. 
Therefore it is suggested that further studies should be 
carried out covering the maximum duration of the 
study, the maximum number of positive patients, and 
if possible to cover a higher number of deaths reported 
so far, to correlate different risk factors with morbidity 
and mortality of COVID-19. 
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